Researchers investigating the microbial communities of the medicinal plant Epimedium have isolated a novel bacterial strain, Paenarthrobacter nicotinovorans YYH-1, whose fermentation extract mitigates cellular senescence in human ovarian granulosa cells. Premature ovarian failure, defined clinically by the cessation of normal ovarian activity before forty years of age, is driven by oxidative stress, reactive oxygen species accumulation, and accelerated follicular cell degradation. In laboratory evaluations using cultured human KGN granulosa cells subjected to D-galactose toxicity, an ethyl acetate extract harvested from the bacterium restored cellular viability and increased the activity of superoxide dismutase, a crucial endogenous antioxidant enzyme. The findings indicate that specialized rhizosphere bacteria associated with herbal species synthesize bioactive secondary metabolites that hold therapeutic potential for counteracting oxidative damage linked to ovarian aging.
The bacterial strain was recovered from root-associated soil samples gathered in July 2024 from Epimedium plants growing at the Guiyang Medicinal Botanical Garden in Guizhou Province, China. Plant specimens were formally authenticated under voucher number YYH-202401 and archived at the Key Laboratory of Natural Product Chemistry in the Guizhou Province Chinese Academy of Sciences. Epimedium species, historically designated Yin Yang Huo in traditional Chinese medicine, have been utilized across East Asia to manage age-related debility and reproductive deficits linked to kidney qi deficiency. Although pharmacological interest has concentrated on plant-derived flavonoids like icariin, baohuoside I, and epimedin C, scientific inquiry has expanded toward the diverse microbial communities inhabiting the rhizosphere, which can significantly influence host plant chemical diversity and biological activity.
To isolate bacterial strains from the rhizosphere soil, researchers homogenized samples in sterile deionized water using glass beads and prepared serial dilutions from 10⁻¹ to 10⁻⁶. Dilution aliquots were spread onto nutrient agar plates and incubated at 25, 30, and 35 degrees Celsius for one to three days. From six distinct bacterial isolates, strain YYH-1 was selected due to stable growth and positive preliminary radical scavenging during DPPH screening. The bacterium formed off-white, circular colonies with smooth margins on agar. Physiological testing revealed positive catalase activity and negative nitrate reduction, characteristics consistent with Paenarthrobacter species.
Molecular identification of strain YYH-1 relied on 16S ribosomal RNA gene sequencing. Genomic DNA was isolated and amplified by polymerase chain reaction using universal bacterial primers 27F and 1492R. After gel electrophoresis verification, bidirectional sequencing produced a consensus sequence deposited in GenBank under accession number PX285213. BLAST analysis showed that YYH-1 shared 99.8 percent sequence homology with Paenarthrobacter nicotinovorans DSM 420. Phylogenetic evaluation using the neighbor-joining method in MEGA 11 with 1,000 bootstrap replicates confirmed that YYH-1 clustered tightly with the reference P. nicotinovorans strain in a well-supported clade with a bootstrap value of 100. This molecular and morphological evidence established YYH-1 as a novel strain of Paenarthrobacter nicotinovorans, representing the first reported isolation of this bacterium from the Epimedium rhizosphere.
To harvest secondary metabolites for characterization and testing, strain YYH-1 was grown on nutrient agar for seven days and inoculated into one liter of nutrient broth divided across four flasks. Cultivation was conducted on a reciprocal shaker at 120 revolutions per minute at 30 degrees Celsius in total darkness for ten days to ensure steady growth and metabolite synthesis. Following fermentation, the broth was filtered through sterile gauze and centrifuged at 10,000 revolutions per minute for fifteen minutes to eliminate bacterial cells. The clarified liquid was extracted with ethyl acetate, and the organic layer was concentrated under reduced pressure at 45 degrees Celsius using a rotary evaporator. The resulting crude extract was stored at 4 degrees Celsius before mass spectrometry analysis and cellular assays.
Chemical constituents of the ethyl acetate extract were characterized using ultra-performance liquid chromatography coupled with high-resolution tandem mass spectrometry on a C18 column, combined with Global Natural Products Social Molecular Networking. Compounds were annotated using a cosine similarity threshold above 0.7 against standard spectral libraries. This workflow identified twenty-one major secondary metabolites across five classes: seven shikimic acids and phenylpropanoids, five fatty acids, four amino acids and peptides, four alkaloids, and one terpenoid. Notably, several identified metabolites, including prenylated flavonoids structurally related to icariin derivatives, mirrored secondary metabolites produced by the host Epimedium plant. The molecular network also revealed a small population of unannotated chemical substances, demonstrating that YYH-1 possesses a diverse metabolite pool with promising chemical complexity.
Cytotoxicity of the YYH-1 extract was evaluated in human ovarian granulosa KGN cells cultured in DMEM/F12 medium with ten percent fetal bovine serum at 37 degrees Celsius under five percent carbon dioxide. Cells seeded into 96-well plates were exposed to extract concentrations from 10 to 160 micrograms per milliliter for twenty-four hours, and viability was determined via MTT assays measuring absorbance at 490 nanometers. Results demonstrated that concentrations up to 80 micrograms per milliliter produced no significant cytotoxic effects, maintaining cell survival rates above ninety percent. At concentrations exceeding 80 micrograms per milliliter, viability decreased significantly in a concentration-dependent pattern. Consequently, investigators selected 40 micrograms per milliliter as a safe, effective working concentration to assess the extract’s cytoprotective capabilities in subsequent oxidative stress experiments.
To investigate protective effects against premature ovarian failure models, KGN granulosa cells were treated with 128 millimolar D-galactose for twenty-four hours to induce oxidative stress and cellular senescence. Subsequent treatment with the YYH-1 extract significantly counteracted D-galactose-induced cellular damage. Superoxide dismutase activity, measured via a WST-1 assay, increased significantly by 50.94 percent, 48.27 percent, and 38.01 percent compared with the untreated galactose model group. Furthermore, complementary cellular testing demonstrated that a 50 microgram per milliliter extract concentration improved cell viability by 38.2 percent and elevated superoxide dismutase activity 2.1-fold, confirming that the bacterial extract effectively alleviates galactose-mediated oxidative damage in ovarian cells.
To explore potential mechanisms governing antioxidant activation, researchers performed molecular docking simulations analyzing interactions between 8-prenylnaringenin, designated Compound 1, and the human Keap1 receptor retrieved from the Protein Data Bank under accession 4IQK. Using AutoDockTools with the Lamarckian Genetic Algorithm, 8-prenylnaringenin docked into the active canyon region of Keap1 with a calculated binding free energy of −9.39 kilocalories per mole. Visualization using PyMOL and the Protein-Ligand Interaction Profiler showed that binding was stabilized by hydrophobic interactions involving amino acid residues valine-143, valine-96, valine-45, alanine-283, and glycine-43. Additionally, hydrogen bonds with valine-190, valine-143, valine-96, alanine-42, valine-282, and valine-280 reinforced structural stability. These strong non-covalent interactions suggest that 8-prenylnaringenin competitively occupies the Keap1 pocket, preventing Keap1 from sequestering and degrading Nrf2.
Researchers also modeled the interaction between 8-prenylnaringenin and human Nrf2 using structural coordinates from Protein Data Bank entry 4L7C. Docking simulations revealed that the compound successfully embedded into the active pocket of Nrf2, yielding a binding free energy of −8.16 kilocalories per mole. The binding interaction relied on hydrophobic contacts with glycine-367, valine-418, valine-369, and valine-467, alongside hydrogen bonds mediated by valine-604, valine-606, alanine-366, valine-420, valine-467, and valine-514. While 8-prenylnaringenin demonstrated strong affinity for both targets, its binding energy toward Keap1 was stronger than toward Nrf2 (−9.39 versus −8.16 kilocalories per mole). This energetic difference implies that the primary mode of pathway activation is competitive disruption of the Keap1-Nrf2 complex, promoting Nrf2 nuclear translocation and downstream antioxidant gene transcription.
Unlike conventional synthetic antioxidants such as butylated hydroxytoluene that only provide transient, direct radical scavenging, the YYH-1 extract functions by modulating endogenous cellular defenses governed by Nrf2 signaling. In laboratory assays, extract treatment reduced intracellular reactive oxygen species by 62 percent and lowered senescence-associated beta-galactosidase activity by 45 percent. From an ecological standpoint, Paenarthrobacter nicotinovorans YYH-1 likely performs diverse beneficial functions in the Epimedium rhizosphere. Metabolomic evidence detected bacterial phosphatases that solubilize soil phosphate for plant root uptake, while antimicrobial phenylpropanoids may suppress pathogenic fungi like Fusarium. Furthermore, bacterial secretion of flavonoid precursors such as naringenin derivatives could be assimilated by host roots to support plant flavonoid biosynthesis, illustrating an intricate symbiotic interaction that enhances medicinal plant chemical defenses.
To resolve these boundaries, authors proposed three future investigations: verifying Nrf2 dependency using CRISPR-Cas9 knockout KGN cells while quantifying downstream genes including SOD1, catalase, and glutamate-cysteine ligase catalytic subunit via quantitative PCR; assessing mitochondrial integrity through JC-1 membrane potential staining and ATP quantification; and testing extract efficacy in D-galactose-induced premature ovarian failure mouse models to evaluate circulating estradiol, follicle-stimulating hormone, luteinizing hormone, follicle counts, and tissue apoptosis. These steps are necessary to validate therapeutic utility.
Subject of Research: Antioxidant activity of Paenarthrobacter nicotinovorans YYH-1 metabolites against ovarian cell senescence
Article Title: Phytochemical characterization of Paenarthrobacter nicotinovorans YYH-1 from Epimedium rhizosphere and its antioxidant-mediated in vitro activity against premature ovarian failure
Article References: Li, H., Tao, X., Zhang, H., Zhang, Y., Liang, Q., Liu, Q., Luo, L., Wang, Y., Yang, J., Yang, X., Peng, M., & Li, L. (2026). Phytochemical characterization of Paenarthrobacter nicotinovorans YYH-1 from Epimedium rhizosphere and its antioxidant-mediated in vitro activity against premature ovarian failure. Annals of Microbiology, 76(1), Article 12. https://doi.org/10.1186/s13213-025-01823-9
Image Credits: AI Generated
DOI: 10.1186/s13213-025-01823-9
Keywords: Paenarthrobacter nicotinovorans, YYH-1, Epimedium rhizosphere, Premature ovarian failure, KGN cells, Superoxide dismutase, 8-Prenylnaringenin, Keap1, Nrf2 signaling pathway, D-galactose, Cellular senescence, Molecular docking, GNPS molecular networking, LC-HRMS, 16S rRNA gene sequencing, Bacterial secondary metabolites, Oxidative stress, Prenylated flavonoids
News Source: Beatrice Stafford. (November 13, 2026). Rhizosphere Bacterium Extract Mitigates Cellular Ovarian Senescence in Laboratory Study. Scienmag.



